Scientists have long known that psychedelics like LSD can help the brain grow new connections. These drugs promote something ...

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations.

A study led by the Sant Pau Research Institute (IR Sant Pau) has succeeded in describing, for the first time in detail, the ...

RVPH Open Label Extension Key Opinion Leader Event Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) held a key opinion ...

Neuroscientists can now make precise genetic tweaks to the neurons that are most affected by brain diseases such as Parkinson ...

These brain changes, in turn, were linked to negative symptoms of schizophrenia specific to motivational deficits, such as difficulties in finding work, relationships or school. The inflammation ...

The researchers explained that while previous studies have identified retinal findings in patients with schizophrenia 2–11 that included inner retinal atrophy, thinner peripapillary ... factors affect ...

The compound also may be useful for treating other neuropsychiatric and neurodegenerative diseases characterized by synaptic loss and brain atrophy. To design the ... to the negative and cognitive ...

Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the hallucinations ... and neurodegenerative diseases characterized by synaptic loss and brain atrophy. To ...

Summary: A new LSD-derived compound called JRT shows promise for treating schizophrenia and other brain disorders ... neurodegenerative diseases characterized by synaptic loss and brain atrophy. JRT ...

A study published in the Journal of Clinical Sleep Medicine explores the association between sleep architecture and brain atrophy in regions vulnerable to Alzheimer's Disease (AD) in middle-aged and ...